Geode Capital Management LLC Has $1.55 Billion Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Geode Capital Management LLC lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 2.1% during the third quarter, HoldingsChannel reports. The institutional investor owned 3,820,736 shares of the company’s stock after selling 81,109 shares during the period. Geode Capital Management LLC’s holdings in HCA Healthcare were worth $1,546,584,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the business. Terra Nova Asset Management LLC lifted its stake in shares of HCA Healthcare by 0.3% in the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after purchasing an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV lifted its stake in shares of HCA Healthcare by 7.4% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after purchasing an additional 29 shares during the last quarter. Waldron Private Wealth LLC lifted its position in HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after acquiring an additional 29 shares during the last quarter. Brookstone Capital Management lifted its position in HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after acquiring an additional 30 shares during the last quarter. Finally, UMB Bank n.a. lifted its position in HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after acquiring an additional 30 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on HCA shares. Morgan Stanley started coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price for the company. Royal Bank of Canada boosted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Oppenheimer upped their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. KeyCorp cut their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Finally, UBS Group upped their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $380.29.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,155 shares of company stock valued at $5,608,990. Corporate insiders own 1.70% of the company’s stock.

HCA Healthcare Stock Performance

HCA stock opened at $316.78 on Wednesday. The business’s fifty day moving average is $362.09 and its 200-day moving average is $358.91. The company has a market cap of $80.24 billion, a P/E ratio of 14.22, a price-to-earnings-growth ratio of 1.23 and a beta of 1.63. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a twelve month low of $255.73 and a twelve month high of $417.14.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.83%. HCA Healthcare’s dividend payout ratio is 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.